Status:

RECRUITING

Pan Tumor Rollover Study

Lead Sponsor:

Bristol-Myers Squibb

Collaborating Sponsors:

Exelixis

Novartis

Conditions:

Cancer

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

Main Objective of this study is to examine long-term safety of nivolumab monotherapy including combinations and other cancer therapies in various tumor types.

Eligibility Criteria

Inclusion Criteria

  • Signed Written Informed Consent.
  • Eligible to receive continued study treatment per the Parent Study, including treatment beyond progression per investigator assessment in the Parent Study.
  • On treatment hold in the Parent Study following long-lasting response or are eligible for treatment rechallenge as defined in the Parent Study.
  • WOCBP and male participants who are sexually active must agree to follow instructions for method(s) of contraception as described below and included in the ICF.

Exclusion Criteria

  • Participant is not eligible for study treatment per the Parent Study eligibility criteria.
  • Participants not receiving clinical benefit as assessed by the Investigator.
  • Any clinical adverse event (AE), laboratory abnormality, or intercurrent illness which, in the opinion of the Investigator, indicates that participation in the study is not in the best interest of the participant.
  • Other protocol-defined Inclusion/Exclusion Criteria apply

Key Trial Info

Start Date :

August 9 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 25 2029

Estimated Enrollment :

1500 Patients enrolled

Trial Details

Trial ID

NCT03899155

Start Date

August 9 2019

End Date

August 25 2029

Last Update

April 1 2026

Active Locations (399)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 100 (399 locations)

1

Local Institution - 0220

Huntsville, Alabama, United States, 35801

2

University of Arizona College of Medicine

Tucson, Arizona, United States, 85724

3

Innovative Clinical Research Institute

Lynwood, California, United States, 90262

4

Local Institution

San Francisco, California, United States, 94115

Pan Tumor Rollover Study | DecenTrialz